CONTRAINDICATED PRODUCT ADMINISTERED

Adverse reaction reported in 153,442 FDA reports across 22 drugs.

153,442
Total Reports
22
Drugs Involved
Abatacept
Most Reported Drug

Drugs Associated with CONTRAINDICATED PRODUCT ADMINISTERED

Drugs where "CONTRAINDICATED PRODUCT ADMINISTERED" was reported as an adverse event.

# Drug Reports % of Total
1 Abatacept 13,901
9.1%
2 Methotrexate 13,055
8.5%
3 Tocilizumab 12,016
7.8%
4 Leflunomide 11,767
7.7%
5 Rituximab 10,225
6.7%
6 Infliximab 9,955
6.5%
7 Sulfasalazine 9,546
6.2%
8 Tofacitinib 8,379
5.5%
9 Golimumab 8,345
5.4%
10 Certolizumab Pegol 8,167
5.3%
11 Cetirizine 6,513
4.2%
12 Hydroxychloroquine 6,490
4.2%
13 Alendronate 6,304
4.1%
14 Diclofenac 6,085
4.0%
15 Desoximetasone 6,014
3.9%
16 Cortisone 4,464
2.9%
17 Pseudoephedrine 3,816
2.5%
18 Adalimumab-Aaty 3,204
2.1%
19 Adalimumab-Fkjp 3,204
2.1%
20 Gluconate 932
0.6%
21 Anakinra 841
0.5%
22 Naltrexone Hydrochloride / Bupropion Hydrochloride 219
0.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused contraindicated product administered. Always consult your healthcare provider.